Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting

BACKGROUND: Deciding when to biopsy a man with non-suspicious DRE findings and tPSA in the 4–10 ng/ml range can be challenging, because two-thirds of such biopsies are typically found to be benign. The Prostate Health Index (phi) exhibits significantly improved diagnostic accuracy for prostate cance...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Jay, Shenoy, B. Vittal, Tutrone, Ronald F., Karsh, Lawrence I., Saltzstein, Daniel R., Harmon, William J., Broyles, Dennis L., Roddy, Tamra E., Lofaro, Lori R., Paoli, Carly J., Denham, Dwight, Reynolds, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895603/
https://www.ncbi.nlm.nih.gov/pubmed/29158509
http://dx.doi.org/10.1038/s41391-017-0008-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895603/
https://www.ncbi.nlm.nih.gov/pubmed/29158509
http://dx.doi.org/10.1038/s41391-017-0008-7

Ejemplares similares